StockTipsArenaBeta

BUY Jubilant Ingrevia Limited — Sachin Janardan Sarvade, IDBI Capital Markets and Securities

BUYJubilant Ingrevia Limited
Jubilant Ingrevia share price target & all analyst calls

bySachin Janardan Sarvade, IDBI Capital Markets and SecuritiesHorizon: NA (inferred Swing (≤2wk))22 Jul 2026via NDTV Profit (Live)

Entry₹745.1Inferred
Target₹870
Total upside +16.76% (call closed)
Stop loss₹645-13.43% risk
At expiry₹751.654 Aug 2026, 3:30 pm
Expired+0.88%
Follow Sachin Janardan Sarvade for new calls(13% target hit, 87 closed calls)Get alertsWatch JUBLINGREA for new buy/sell callsGet alertsSee 147 active Swing picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 4 Aug 2026
1 supporting2 neutral1 opposing
Supports the BUY call (1)

Jubilant Ingrevia Q1 Result: Net Profit Up 40%, Revenue Rises 25% To Rs 1,300 Crore

NewsNdtv-Profit·22 Jul · 2w ago

(opens in new tab)
Neutral / worth noting (2)

Jubilant Ingrevia Ltd announced the outcome of its Board Meeting held on July 22, 2026. The board approved the Unaudited Standalone and Consolidated Financial Results for the quarter ended June 30, 20

BSE · Board Meeting·22 Jul · 2w ago

(opens in new tab)

Jubilant Ingrevia Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026.

NSE · Outcome of Board Meeting·22 Jul · 2w ago

(opens in new tab)
Weighs against the BUY call (1)

Jubilant Ingrevia shares gives up post-results gains despite strong June quarter earnings

NewsCnbc-Tv18·22 Jul · 2w ago

(opens in new tab)

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Jubilant Ingrevia

All analyst calls on Jubilant Ingrevia

More from Sachin Janardan Sarvade, IDBI Capital Markets and Securities

Every call and its outcome